Considering that both TN and HER2-enriched BrCa feature a more dysregulated and immunosuppressive KP compared to the less aggressive luminal subtype, it would be interesting to assess the inhibition of KMO and KYNU, which lead to AA and 3HAA, respectively, in animal models of TN breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.